financetom
Business
financetom
/
Business
/
Algoma Steel Fiscal Q3 Loss Narrows, Revenue Declines; Keeps Dividend of $0.05 a Share
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Algoma Steel Fiscal Q3 Loss Narrows, Revenue Declines; Keeps Dividend of $0.05 a Share
Mar 13, 2025 1:22 AM

03:58 AM EDT, 03/13/2025 (MT Newswires) -- Algoma Steel Group ( ASTL ) reported late Wednesday fiscal Q3 net loss of CA$0.61 ($0.42) per diluted share, narrower than the CA$0.78 loss per share a year earlier.

Revenue for the quarter ended Dec. 31 was CA$590.3 million, down from CA$615.4 million.

The company's board has approved an unchanged quarterly dividend of $0.05 per share, payable on April 10 to shareholders as of March 21, it said.

Analysts estimates were not available for comparison.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: JPMorgan Chase's Head of Mergers, Acquisitions for Southeast Asia to Join Citigroup
Market Chatter: JPMorgan Chase's Head of Mergers, Acquisitions for Southeast Asia to Join Citigroup
Jun 12, 2024
04:01 PM EDT, 06/12/2024 (MT Newswires) -- JPMorgan Chase's ( JPM ) head of mergers and acquisitions in Southeast Asia has resigned to join Citigroup ( C ) as director of sector coverage including oil and gas for the region, Bloomberg reported Wednesday, citing people familiar with the matter. Johannes Roth had been JPMorgan's ( JPM ) head of Southeast...
AstraZeneca Gets FDA Approval for Pediatric Type-2 Diabetes Control Drug
AstraZeneca Gets FDA Approval for Pediatric Type-2 Diabetes Control Drug
Jun 12, 2024
04:00 PM EDT, 06/12/2024 (MT Newswires) -- AstraZeneca ( AZN ) said Wednesday that Farxiga has received approval from the US Food and Drug Administration to improve glycaemic control in children aged 10 and older with type-2 diabetes. Farxiga, or dapagliflozin, is an oral medication, taken once daily, that acts as a sodium-glucose cotransporter 2 inhibitor, AstraZeneca ( AZN )...
Warner Bros. Discovery Unusual Options Activity For June 12
Warner Bros. Discovery Unusual Options Activity For June 12
Jun 12, 2024
Investors with a lot of money to spend have taken a bullish stance on Warner Bros. Discovery ( WBD ) . And retail traders should know. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know. But when something...
Update: Nike Reportedly Loses Trademark Bid for 'Footware' to Puma in European Court; Ordered to Pay Legal Costs
Update: Nike Reportedly Loses Trademark Bid for 'Footware' to Puma in European Court; Ordered to Pay Legal Costs
Jun 12, 2024
04:07 PM EDT, 06/12/2024 (MT Newswires) -- (Updates with Puma's response in the third paragraph.) Nike's ( NKE ) trademark application for the capitalized version of the word footware was dismissed by the General Court of the European Union and the shoemaker was ordered to pay legal costs in Puma's favor, media reports said Wednesday. Nike ( NKE ) may...
Copyright 2023-2026 - www.financetom.com All Rights Reserved